DC Duo

País: Nueva Zelanda

Idioma: inglés

Fuente: Ministry for Primary Industries

Ingredientes activos:

bismuth subnitrate; ampicillin trihydrate; chlorhexidine (free acid); cloxacillin benzathine

Disponible desde:

Elanco New Zealand

Designación común internacional (DCI):

bismuth subnitrate, cloxacillin benzathine, chlorhexidine, ampicillin trihydrate

Composición:

bismuth subnitrate 650 g/kg; ampicillin trihydrate 55.55 g/kg; chlorhexidine (free acid) 5.25 g/kg; cloxacillin benzathine 111.1 g/kg

Área terapéutica:

Antibiotic

Estado de Autorización:

ACVM Registered

Fecha de autorización:

2014-04-08

Ficha técnica

Bucket label (main panel)
Issue date: 25 July 2023
_The information above this line is not included in the label _
DANGER
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
HIGHLY IMPORTANT ANTIBIOTIC
DC Duo
DRY COW INTRAMAMMARY ANTIBIOTIC + TEAT SEALANT
XXX INJECTORS
Bucket label (left panel)
Issue date: 25 July 2023
_The information above this line is not included in the label _
DC Duo dry cow therapy, is a sterile product consisting of a common
injector applicator containing 2
existing products, Dryclox AF (the intramammary suspension mix of
cloxacillin benzathine and ampicillin
trihydrate) and Intercept (the intramammary teat sealant which
contains bismuth subnitrate and
chlorhexidine). The injector presents a convenient applicator for
single use thus minimising the risk of
introduction of new infections during administration.
Cloxacillin and ampicillin are both semi-synthetic penicillins derived
from 6-aminopenicillanic acid, while
the Intercept portion prevents mastitis from new infections by forming
a physical barrier at the entry of the
teat canal.
Active Constituent: Each 8.5g syringe contains 1 dose of each of two
products in a long-acting oily base:
Cloxacillin (as the benzathine salt) 500mg and Ampicillin (as the
trihydrate) 250mg in the front half near
the nozzle, and bismuth subnitrate 2.6g and chlorhexidine 20mg
(0.5%w/w) in the rear half of the injector.
INDICATIONS
DC Duo is packed to be administered as a simultaneous application of
two suspension products for dry
cow therapy. It is formulated for use in the dairy cow at the point of
drying off, that is as soon as possible
after the last milking of the lactation, in order to treat existing
mastitis and to provide protection against
further infections during the dry period.
The antibiotic portion of DC Duo is effective against _Streptococcus
uberis_ and other _Streptococcus_ spp.,
penicillin-resistant and sensitive _Staphylococcus _spp.
The effective antibacterial levels in the dry udder are maintained for
up to